Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2010 by National Taiwan University Hospital.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Bristol-Myers Squibb
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00597259
First received: January 9, 2008
Last updated: June 28, 2010
Last verified: June 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2014
  Estimated Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)